Compare PNNT & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNNT | ACB |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.4M | 232.3M |
| IPO Year | 2007 | 2016 |
| Metric | PNNT | ACB |
|---|---|---|
| Price | $3.58 | $3.72 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.75 | N/A |
| AVG Volume (30 Days) | 472.1K | ★ 1.5M |
| Earning Date | 05-07-2026 | 06-17-2026 |
| Dividend Yield | ★ 20.87% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.31 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.14 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.19 | $2.56 |
| 52 Week High | $7.06 | $6.67 |
| Indicator | PNNT | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 42.54 | 54.25 |
| Support Level | $3.31 | $3.27 |
| Resistance Level | $3.59 | $3.91 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 6.45 | 3.75 |
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.